COLİSTİMAT 150 mg Powder for I.M/I.V. Injection and Inhalation

Used for the treatment of sepsis, meningitis, disseminated Lyme borreliosis, abdominal infections, bone and joint infections, soft-tissue, skin and wound infections, infections associated with immune system disorders, kidney and urinary tract infections, respiratory tract and ear, nose and throat infections, and genital infections including gonorrhea caused by susceptible pathogens, as well as for preoperative infection prophylaxis.

It is used in all age groups for the treatment of complicated skin and soft-tissue infections, bone and joint infections, community-acquired pneumonia, hospital-acquired pneumonia—including ventilator-associated pneumonia—and infective endocarditis; for perioperative antibacterial prophylaxis in patients at high risk of bacterial endocarditis; and, when administered orally, for the treatment of Clostridium difficile infections.

It is used in all age groups for the treatment of complicated skin and soft-tissue infections, bone and joint infections, community-acquired pneumonia, hospital-acquired pneumonia—including ventilator-associated pneumonia—and infective endocarditis; for perioperative antibacterial prophylaxis in patients at high risk of bacterial endocarditis; and, when administered orally, for the treatment of Clostridium difficile infections.

It is used for the treatment of serious respiratory tract, urinary tract, and genital tract infections caused by microorganisms susceptible to cefotaxime; septicemia, bacteremia, endocarditis, and intra-abdominal infections, including peritonitis; meningitis and other central nervous system infections; and infections of the skin and soft tissues, bones, and joints. It is also used for prophylaxis in gastrointestinal, genitourinary, obstetric, and gynecological surgery.